Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Decreases By 5.7%

Clearmind Medicine Inc. (NASDAQ:CMND) was the recipient of a significant drop in short interest during the month of September. As of September 15th, there was short interest totalling 231,900 shares, a drop of 5.7% from the August 31st total of 245,800 shares. Based on an average trading volume of 1,610,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 7.8% of the shares of the company are short sold.

Institutional Trading of Clearmind Medicine

A hedge fund recently bought a new stake in Clearmind Medicine stock. Cornerstone Wealth Group LLC purchased a new stake in Clearmind Medicine Inc. (NASDAQ:CMND) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 20,000 shares of the company’s stock, valued at approximately $34,000. Cornerstone Wealth Group LLC owned about 1.18% of Clearmind Medicine at the end of the most recent quarter. Hedge funds and other institutional investors own 96.05% of the company’s stock.

Clearmind Medicine Stock Performance

Shares of CMND traded down $0.02 during mid-day trading on Monday, reaching $1.23. The company’s stock had a trading volume of 20,421 shares, compared to its average volume of 1,525,598. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.71 and a current ratio of 1.71. Clearmind Medicine has a 1-year low of $0.92 and a 1-year high of $10.35. The business has a 50-day simple moving average of $1.35 and a two-hundred day simple moving average of $1.31.

Clearmind Medicine (NASDAQ:CMND) last announced its quarterly earnings results on Monday, September 16th. The company reported ($0.59) earnings per share (EPS) for the quarter.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.